Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-News: Imcyse SA / Key word(s): Miscellaneous Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis 22.06.2023 / 10:30 CET/CEST The issuer is solely responsible for the content of this announcement. Imcy...
Issuer: Mainz BioMed N.V. / Key word: Miscellaneous Mainz BioMed N.V.: Mainz Biomed Expands into Romania Through Partnership with Bioclinica 20.06.2023 / 09:01 CET/CEST The... | June 20, 2023
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous Mainz BioMed N.V.: Mainz Biomed Expands into Romania Through Partnership with Bioclinica 20.06.2023 /...
INV501, a potentially first-in-class compound, induces strong anti-tumor immune responses in preclinical models in different solid tumor indicationsTreatment with INV501 significantly inhibits tumor growth, extends survival and increases cure rates even after end of treatmentINV501 is an orally available compound with good bioavailability and favorable pharmacokinetic profile VIENNA, Austria, June 19, 2023 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company develop
The award recognizes a significant capital market transaction in the biotech sector. Abivax received the award for its oversubscribed EUR 130M cross-over financing at market price with top-tier US... | June 19, 2023